Skip to content

To Study The Use Of Sarivadi Kwath For Reducing Vommiting In Pregnancy

Randomized Controlled Clinical Study To Evaluate The Efficacy Of Sarivadi Kwath In The Management Of Garbhini Chhardi W.S.R To Emesis Gravidarum. - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/06/089551
Enrollment
80
Registered
2025-06-25
Start date
Unknown
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O00-O9A- Pregnancy, childbirth and the puerperium

Interventions

None listed

Sponsors

Dr Prajakta Babasaheb Dome
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. All patients diagnosed with 6th to 14th weeks of single live intrauterine pregnancy (primi and multi gravida) irrespective of parity & religion having complaints of vomiting in preganacy will be selected. 2. Married female patient between age of 21 35 years.

Exclusion criteria

Exclusion criteria: 1. Patients with second and third trimester. 2. Garbhini with Hyperemesis Gravidarum. 3. Pregnant women with vomiting due to other systemic Diseases Such as intestinal obstruction, appendicitis, Cholecystitis, hypertension, jaundice etc. 4. Known case of diabetes mellitus. 5. Multiple pregnancy.

Design outcomes

Primary

MeasureTime frame
To study the effect of Sarivadi kwath on Garbhini Chhardi W.S.R. to Emesis GravidarumTimepoint: 15th,30th and 45th day

Secondary

MeasureTime frame
1)Correlating Clinical Presentation Of Garbhini Chhardi With Nidana Samprapti , Dosha Involvement And Etiopathology Of Emesis Gravidarum 2)Assesing The Frequency And Severity Of Nausea & Vommiting 3)To Study The Efficacy In Reducing Associated Symptoms Of Garbhini ChhardiTimepoint: 15th,30th & 45th day

Countries

India

Contacts

Public ContactDr Deepti Paithankar

Matoshree Asarabai Darade Ayurved Mahavidyalay Babulgaon Tal-Yeola Dist-Nashik

deeptisonawane3@gmail.com8668735193

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026